Michael D Ezekowitz

Author PubWeight™ 0.75^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Response to letter regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial analysis".	Circulation	2014	0.75
2	Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.	Am Heart J	2017	0.75